with Prostate Cancer Risk: A Meta-Analysis of 57 Studies

polymorphisms and prostate cancer (PCa) risk report conflicting results, therefore, we conducted a meta-analysis to re-examine the controversy. polymorphisms. A131G polymorphism (OR = 1.0845, 95% CI = 0.96–1.2251) and the PCa risk. A131G polymorphism and the risk of PCa. Further rigorous analytical studies are highly expected to confirm our conclusions and assess gene-environment interactions with PCa risk